T B Okarma
About
In The Last Decade
T B Okarma
23 papers receiving 642 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 279
- Immunology 219
- Genetics 158
- Epidemiology 97
- Hematology 89
Countries citing papers authored by T B Okarma
This map shows the geographic impact of T B Okarma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T B Okarma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T B Okarma more than expected).
Fields of papers citing papers by T B Okarma
This network shows the impact of papers produced by T B Okarma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T B Okarma. The network helps show where T B Okarma may publish in the future.
Co-authorship network of co-authors of T B Okarma
This figure shows the co-authorship network connecting the top 25 collaborators of T B Okarma. A scholar is included among the top collaborators of T B Okarma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T B Okarma. T B Okarma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 2 | |
| 3 | 45 | |
| 4 | 3 | |
| 5 | Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection. | 26 |
| 6 | 4 | |
| 7 | 73 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 88 | |
| 11 | The AIS CELLector: a new technology for stem cell purification. | 6 |
| 12 | Phase 1 Trial of Adoptive Therapy with Purified CD8 Cells in HIV Infection | 0 |
| 13 | 69 | |
| 14 | 82 | |
| 15 | Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer. | 36 |
| 16 | 59 | |
| 17 | 5 | |
| 18 | 25 | |
| 19 | 11 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.